HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Post-TAVR Pacemakers Linked to Higher Mortality Risk

By Daniel Beris
Posted on 22 Nov 2016
Print article
Permanent pacemaker (PPM) implantation soon after transcatheter aortic valve replacement (TAVR) often leads to worse outcomes, according to a new study.

Researchers at the Reading Health System (West Reading, PA, USA), Thomas Jefferson University (TJU; Philadelphia, PA, USA), and other institutions conducted a retrospective cohort study of 9,785 patients undergoing TAVR in the United States at 229 sites between November 2011 and September 2014. Of these, 651 needed a permanent pacemaker within 30 days of the TAVR procedure. The researchers then used the data to evaluate the incidence, predictors, and clinical outcomes of PPM implantation following TAVR.

The results showed that PPM needs varied among those receiving self-expanding valves (25.1%) versus balloon-expanding valves (4.3%). Positive predictors of PPM implantation were age, prior conduction defect, and use of self-expanding valve. PPM implantation was also associated with longer median hospital stay, intensive care unit (ICU) stay, increased mortality, and a composite of mortality or heart failure admission at one year, but not with heart failure admission alone. The study was published in the November 2106 issue of JACC: Cardiovascular Interventions.

“While pacemakers can and do help save lives, what our study shows is that when they are placed within a month post-TAVR, they may be associated with worsened outcomes as compared to those who did not need pacemakers,” said lead author Opeyemi Fadahunsi, MBBS, MPH, of Reading Health System. “While TAVR is a great advance in medical care, cardiologists need to better understand both how to prevent patients from developing heart rhythm problems, and why patients who need pacemakers in the setting of recent TAVR have worsened outcomes.”

The percutaneous treatment of severe aortic valve disease using a TAVR prosthetic aortic valve replacement, without the need for open-heart surgery or cardiopulmonary bypass, is faster and less invasive than current open-heart procedures. TAVR has so far been proven effective in high-risk and inoperable patients, and could soon become the standard of care, even in moderate and low surgical risk patients.

Related Links:
Reading Health System
Thomas Jefferson University
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Acute Care Scale
PH-740

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more